Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Y Cheung

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Hybridoma and Hybridomics|September 27, 2003
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapyNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
Pediatric Blood & Cancer|June 16, 2016
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adultsKonstantin Dobrenkov, Irina Ostrovnaya, Jessie Gu, et al.
Cancer Letters|June 14, 2005
Detecting minimal residual disease in neuroblastoma patients-the present state of the artKlaus Beiske, Peter F Ambros, Susan A Burchill, et al.
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastomaIrene Y Cheung, Yi Feng, Andrew Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Oncoimmunology|July 4, 2012
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoNai-Kong V Cheung, Hongfen Guo, Jian Hu, et al.
The Journal of Biological Chemistry|April 9, 2015
Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8Qi Zhao, Mahiuddin Ahmed, Hong-fen Guo, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remissionBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Hybridoma and Hybridomics|September 27, 2003
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapyNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
Pediatric Blood & Cancer|June 16, 2016
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adultsKonstantin Dobrenkov, Irina Ostrovnaya, Jessie Gu, et al.
Cancer Letters|June 14, 2005
Detecting minimal residual disease in neuroblastoma patients-the present state of the artKlaus Beiske, Peter F Ambros, Susan A Burchill, et al.
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastomaIrene Y Cheung, Yi Feng, Andrew Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Oncoimmunology|July 4, 2012
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoNai-Kong V Cheung, Hongfen Guo, Jian Hu, et al.
The Journal of Biological Chemistry|April 9, 2015
Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8Qi Zhao, Mahiuddin Ahmed, Hong-fen Guo, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remissionBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Pageof 5